ABSTRACT Epidermal growth factor (EGF) as well as prostaglandin F2 (PGF2 ), when added to quiescent, confluent Swiss 3T3 cells, stimulate the initiation of DNA synthesis, which occurs with apparent first-order kinetics after a lag phase of 14-15 hr. These two growth factors appear to stimulate similar events; insulin enhances and hydrocortisone can inhibit the stimulatory effect of either. Here Normal animal cells in an environment containing many different growth factors and hormones are able to regulate their rate of proliferation by a variety of poorly understood mechanisms (1-3). One approach to the understanding of the regulatory mechanisms requires the elucidation of the signals and molecular events that are delivered by growth factors and lead to chromosomal DNA replication (4-6). Serum (7) and growth factors such as epidermal growth factor (EGF) (8, 9), fibroblast growth factor (10, 11), and prostaglandin F2. (PGF2.) (12) stimulate the initiation of DNA synthesis in cultures of quiescent, confluent Swiss mouse 3T3 cells by regulating two different phenomena: the progression through the prereplicative period (lag phase; US1 hr) and the rate of entry into the S phase (6, (12) (13) (14) (15) . These two phenomena, studied with defined growth factors, have been interpreted as requiring the existence of two signals: signal 1 and signal 2 (6, 12, 15). The lag phase (induced by signal 1) has been defined as the time between the initial addition of a growth factor and the initiation of DNA synthesis; it appears to be independent ofthe concentration of the growth factor above a minimal essential concentration. The rate of initiation of DNA synthesis (given by signal 2), however, increases with the growth factor concentration up to a saturating level and can be changed by addition ofthe same growth factor later during the lag phase and by addition of nonmitogenic compounds (12, 15). The resulting rate follows apparent first-order kinetics and can be quantified by a rate constant k (6, 7, (12) (13) (14) (15) .
hr of each other. Addition of one growth factor 10 or 15 hr after the other delayed the synergy for 15 hr after the addition of the second growth factor. Insulin further increased the rate of entry into the S phase stimulated by'EGF and PGF together, whereas hydrocortisone inhibited the stimulatory effect observed with either EGF or PGF2. alone. These results suggest that, in spite ofthe common events responsible for the interactions with the two hormones, EGF and PGF2. must have differences in their sequences of events that initiate DNA synthesis.
Normal animal cells in an environment containing many different growth factors and hormones are able to regulate their rate of proliferation by a variety of poorly understood mechanisms (1) (2) (3) . One approach to the understanding of the regulatory mechanisms requires the elucidation of the signals and molecular events that are delivered by growth factors and lead to chromosomal DNA replication (4) (5) (6) . Serum (7) and growth factors such as epidermal growth factor (EGF) (8, 9) , fibroblast growth factor (10, 11) , and prostaglandin F2. (PGF2.) (12) stimulate the initiation of DNA synthesis in cultures of quiescent, confluent Swiss mouse 3T3 cells by regulating two different phenomena: the progression through the prereplicative period (lag phase; US1 hr) and the rate of entry into the S phase (6, (12) (13) (14) (15) . These two phenomena, studied with defined growth factors, have been interpreted as requiring the existence of two signals: signal 1 and signal 2 (6, 12, 15) . The lag phase (induced by signal 1) has been defined as the time between the initial addition of a growth factor and the initiation of DNA synthesis; it appears to be independent ofthe concentration of the growth factor above a minimal essential concentration. The rate of initiation of DNA synthesis (given by signal 2), however, increases with the growth factor concentration up to a saturating level and can be changed by addition ofthe same growth factor later during the lag phase and by addition of nonmitogenic compounds (12, 15) . The resulting rate follows apparent first-order kinetics and can be quantified by a rate constant k (6, 7, (12) (13) (14) (15) .
There is evidence that in Swiss mouse 3T3 cells growth factors and hormones such as insulin and hydrocortisone regulate the rate constant through different sequences ofcellular events (6, 12, 15) . Although a growth factor alone can induce the initiation process, insulin, hydrocortisone, or other compounds, which alone do not initiate DNA synthesis in these cells, can modulate the stimulatory effect ofthe growth factor and, hence, alter the rate of entry into the S phase (15, 16) . It has also been shown that the interaction of insulin or hydrocortisone (or both) with cells stimulated by EGF, fibroblast growth factor, or PGF2. is dependent on the growth factor and the time of addition during the lag phase. This has suggested that there is a time-dependent sequence of regulatory events occurring during the lag phase that regulate the rate at which the cell population initiates DNA synthesis (6, 15) . Similar conclusions have been drawn from results on the interaction of platelet growth factor with plasma (17) .
A central problem that has remained unresolved is whether two different growth factors act by a common sequence of molecular events or whether they act by different sequences that could converge to regulate the initiation of DNA synthesis. Here we show that EGF and PGF2a added together or one added 6 hr after the other interact in a synergistic manner to initiate DNA synthesis after the lag phase of 15 hr. When one growth factor is added 10 or 15 hr after the other, the length of the lag phase remains constant and the synergistic effect is delayed for 15 hr after the addition of the second growth factor.
These results suggest that EGF and PGF2, operate by different sequences of cellular events to induce progression through the lag phase and to regulate the rate of entry into the S phase.
MATERIALS AND METHODS
Cultures. Swiss mouse 3T3 cells (18) Fig. 1 . EGF (0.5-20 ng/ml) increased the fraction oflabeled nuclei, which reached a plateau of 15% at 10 ng of EGF per ml. Insulin (50 ng/ml), which does not initiate DNA synthesis in 3T3 cells (Table 1 ) (12), had a synergistic effect with EGF; it increased the value of the labeling index from 15% to 39% and shifted the saturating concentration ofEGF to 6 ng/ml (Fig. 1A ). Addition ofEGF with PGF2, alone or together with insulin increased the labeling index even more (to 58% and 78%, respectively), and the saturating concentration of EGF was reduced from 10 ng/ml to 2 ng/ml. The dose-response curves of PGF2a with EGF or insulin (or both) are similar (Fig. 1B) . EGF and insulin decreased the saturating concentration of PGF2 from 100 ng/ml to 10 ng/ ml (Fig. 1B) . EGF and PGF2a, when added at subsaturating concentrations together without or with insulin, gave almost the same synergistic effect as at saturating concentrations (Table 1) . (300 ng/ml). (B) o, PGF2<,; *, PGF2.. plus insulin (50 ng/ml); n, PGF2., plus EGF (20 ng/ml); *, PGF2f. plus insulin (50 ng/ml) and EGF (20 ng/ml). Cultures were exposed to [methyl-3H]thymidine 0-28 hr after additions and were then processed for autoradiography. Labeling index was determined as in Fig. 1 . Cultures were exposed to [methyl-3Hlthymidine 0-28 hr after additions and then processed for autoradiography. Insulin was added at 50 ng/ml. Fatty acids were dissolved in absolute ethanol and diluted so that the final concentration of ethanol in the culture medium was 0.01%.
Among the prostaglandins and fatty acids tested with EGF (Table 1) , the synergistic effect was maximal for PGF2.. The biosynthetic precursors of prostaglandins [arachidonic and linoleic acids (20) ] as well as oleic acid added with EGF or with EGF and insulin had no effect on the labeling index. PGEI (which at 300 ng/ml had only a marginal stimulatory effect with insulin), when added with EGF or with EGF and insulin, enhanced the labeling index only slightly (Table 1) . PGE2, which is similar in structure to PGF2., had some stimulatory effect at 300 ng/ml in the presence of insulin. When added with EGF or with EGF and insulin, PGE2 at 30 ng/ml did not significantly enhance the labeling index; however, at 300 ng/ml it had a synergistic effect, though to a lesser extent than PGF2. Only PGF2,, which initiates DNA synthesis alone, gave the maximal enhancement at 30 ng/ml.
Interactions of EGF, PGF2S, and Hormones During Lag
Phase. How do EGF and PGF2, change the kinetics of the initiation of DNA synthesis when added at different times during the lag phase? EGF (20 ng/ml) or PGF2, (200 ng/ml) added alone increased k from a basal level of 0.06 X 10-2 hr'1 to 1.1 X 10-2 or 1.3 X 10-2 hr-1, respectively, after a lag phase of 14.5 hr ( Fig. 2A) . Addition of EGF and PGF2, together increased the rate constant to 6.1 X 10-2 hr-' without changing the length of the lag phase. For comparison, k for serum was 24.3 x 10-2 hr-1 ( Fig. 2A ). PGF2 added 6 hr after EGF also had a synergistic effect, which was observed immediately upon completion of the lag phase, but k was decreased to 3.1 x 10-2 hr-' (Fig. 2A) . However, when PGF2.Q was added 10 or 15 hr after EGF, the synergistic effect was delayed by 15 hr after the addition of PGF2,; i. e., up to 25 or 30 hr after stimulation by EGF, k was that of EGF alone before it increased from 1.1 x 10-2 to 3.4 X 10-2 or 3.3 X 10-2 hr-, respectively.
The interaction of EGF at different times during the lag phase set by PGF2, followed a similar pattern (Fig. 2B) Proc. NatL Acad. Sci. USA 78 (1981) 1007 been added at the beginning. Furthermore, EGF added 15 hr after PGF2, and insulin resulted in a delay of 15 hr before the rate constant changed abruptly at 30 hr from that of PGF2, and insulin (4.2 x 10-2 hr-1) to that reflecting the full synergistic effect (10.2 x 10-2 hr-1). Thus, the basic pattern ofinteraction between EGF and PGF2, is not altered by the presence of insulin.
The pattern of interaction between EGF and PGF2, is basically different from that of insulin with either EGF or PGF2, (Fig. 3) . Insulin added 6 hr after EGF or PGF2. resulted in a slight loss of the synergistic effect, from 3.5 x 10-2 to 3.1 x 10-2 hr'1 for EGF (Fig. 3A) or from 4.2 x 10-2 to 3.6 x 10-2 hr'1 for PGF2 (Fig. 3B) . However, when insulin was added 15 hr after either growth factor, there was a delay of the synergistic effect of only 6 hr; i.e., the rate constant changed abruptly at about 21 hr from 1.0 x 10-2 to3.1 x 10-2 hr' for EGF (Fig. 3A) or from 1.2 x 10-2 to 3.6 x 10-2 hr'1 for PGF2. (Fig.   3B) .
The effect oftwo different hormones added at different times during the lag phase on the synergy between EGF and PGF2a is shown in Fig. 4 . As already described (Fig. 3 For measurement of 2-deoxyglucose uptake, cells were plated in 30-mm dishes as for determination of DNA synthesis. At 1 and 6 hr after additions were made, cells were labeled for 10 min with 2.5 ,Ci of 2-
[3H]deoxyglucose (50 ,uM). For determination of the cell number, cells were plated at 1.5 x 105 per 50-mm dishes under the same conditions as above. Additions were made when no mitotic figures were present; 54 hr later, the cells were suspended with 0.05% trypsin and counted in isotonic buffer with a Coulter Counter. Concentrations: insulin, 50 ng/ml; EGF, 20 ng/ml; PGF2., 300 ng/ml; cycloheximide, 10 ,ug/ml; and fetal calf serum, 10%. The average variation of experimental values was 10% for 2-deoxyglucose uptake and 5% for the cell number.
ited the synergistic effect between the two growth factors by reducing k from 6.5 x 10-2 to 2.7 X 10-2 hr-' (Fig. 4B) . However, addition of hydrocortisone 9, 15, or 21 hr after EGF and PGF2, had no effect on the initiation of DNA synthesis (Fig.  4B) . The same interaction of hydrocortisone occurred with EGF, PGF2, and insulin. Only when the glucocorticoid was added at the beginning ofthe lag phase was k reduced from 10.8 X 10-2 to 4.3 X 10-2 hr-'. Later additions at 9, 15, or 21 hr had no inhibitory effect. Thus, insulin and hydrocortisone interact with EGF and PGF2 together in the same way as they do with each of these growth factors separately.
The synergistic effects of EGF, PGF2, and insulin on DNA synthesis were also reflected by 2-deoxyglucose uptake (6, 19) . Although insulin and EGF alone each stimulates 2-deoxyglucose uptake only marginally and PGF2, stimulates uptake about 2.5-fold within 6 hr, insulin with either EGF or PGF2, had a synergistic effect ( factors are added together. When a second growth factor is added at 6 hr after the beginning of the lag phase, there may be regulatory events in common that allow cooperation between the events triggered by each growth factor. Yet it appears that there are fewer in common events than when the growth factors are added together inasmuch as the synergistic effect is less.
When the second growth factor is added at 10 or 15 hr, its events can no longer be integrated with those ofthe first growth factor. The cell has then possibly passed the regulatory event(s) occurring before or around 6 hr that allow the events induced by the second growth factor to be integrated during the lag phase set by the first growth factor. However, some biochemical effects of the first growth factor can still interact with regulatory events triggered by the second growth factor because there is a synergistic effect expressed after completion of the second sequence of events.
The long delay in the synergistic effect is in contrast to previous results in which a low, subsaturating concentration of PGF2. (60 ng/ml) was supplemented with a saturating concentration of PGF2a (240 ng/ml) at 15 hr. In this case, the delay in reaching the final value of k is only 4-6 hr (6, 12) . However, when a subsaturating concentration of PFG2a (60 ng/ml) is supplemented with EGF either at subsaturating (2 ng/ml) or saturating (20 ng/ml) concentrations at 15 hr, then the value of k given by PGF2. does not increase until 15 hr after the addition of EGF (unpublished data). This also indicates that some regulatory events during the lag phase are different for EGF and PGF2. because they cannot complement each other at any time of the lag phase as the identical growth factor can.
The synergistic effect among EGF, PGF2a, and insulin agrees with the view of Holley (5) that growth factors, hormones, and nutrients affect different cellular events leading to the initiation of DNA synthesis. The pattern of interactions of the two growth factors supports the concept that each growth factor delivers two different signals, one to set the lag phase with a specific sequence of events and another to regulate the rate of initiation of DNA synthesis (6, 12, 15) . We do not know whether both signals are different or only one of the signals is different for the two growth factors. Our results are difficult to interpret by other models of the cell cycle. In particular, it remains to be seen how these results and the concept of the two signals are compatible with the model oftwo random transitions proposed by Brooks et al. (14) .
Is the synergy between EGF and PGF2a also expressed in any of the biochemical events occurring prior to the initiation of DNA synthesis? The interaction between EGF and PGF2, within the first 6 hr is reflected in the synergistic effect on 2-deoxyglucose uptake. This synergy is observed only on the protein synthesis-dependent phase, not on the early, protein synthesis-independent phase. It could thus be postulated that integration of the events triggered by the two growth factors requires protein synthesis. Indeed, other evidence suggests that the appearance of specific proteins is correlated with the initiation of DNA synthesis (21) . It has been shown that, upon stimulation of quiescent 3T3 cells by PGF2. and insulin, a nuclear, nonhistone protein (M, 33,000) appears at about 15 hr.
However, when DNA synthesis is inhibited by addition of hydrocortisone within 5 hr after PGF2G and insulin, this protein is markedly decreased (6) . These results imply that events occurring early during the lag phase may regulate the activity of a putative initiator at the end of the lag phase. Other levels of control may also be involved. Other biochemical events correlating with the mitogenic response need to be found to enable us to identify the regulatory steps leading to the initiation of DNA synthesis.
